Which HIV-infected adults with high CD4 T-cell counts benefit most from immediate initiation of antiretroviral therapy? A post-hoc subgroup analysis of the START trial

Simple item page
dc.citation.doi10.1016/S2352-3018(18)30003-1
dc.citation.epage180
dc.citation.spage172
dc.contributor.authorJean-Michel Molina
dc.contributor.authorBirgit Grund
dc.contributor.authorFred Gordin
dc.contributor.authorIan Williams
dc.contributor.authorNoluthando Mwelase
dc.contributor.authorE et al
dc.date.accessioned2023-04-13T10:38:37Z
dc.date.available2023-04-13T10:38:37Z
dc.identifier.citationISI
dc.identifier.issn2352-3018
dc.identifier.urihttps://hdl.handle.net/10539/35048
dc.journal.titleLANCET HIV
dc.journal.volume5
dc.titleWhich HIV-infected adults with high CD4 T-cell counts benefit most from immediate initiation of antiretroviral therapy? A post-hoc subgroup analysis of the START trial

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Journal.pdf
Size:
980.31 KB
Format:
Adobe Portable Document Format
Description:
Journal
Download

Collections

Academic Wits Research Outputs (All submissions)